Pan-Canadian FGFR Blood Test Cancer Therapy | AcademicJobs
Discover how a new pan-Canadian ctDNA blood test for FGFR alterations is expanding access to erdafitinib for metastatic urothelial cancer patients, led by UBC and BC Cancer researchers.
research-publication-newscanadian-university-researchbladder-cancer-research

